Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study)-Reference-Cited by-同舟云学术

Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study)

Published:2015-04-29 Issue:8 Volume:22 Page:634-645
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepatobiliary Pancreat Sci

Author:

Hatano Etsuro¹,Okuno Masayuki¹,Nakamura Kojiro¹,Ishii Takamichi¹,Seo Satoru¹,Taura Kojiro¹,Yasuchika Kentaro¹,Yazawa Takefumi²,Zaima Masazumi²,Kanazawa Akiyoshi³,Terajima Hiroaki⁴,Kaihara Satoshi⁵,Adachi Yukihito⁶,Inoue Naoya⁷,Furumoto Katsuyoshi⁸,Manaka Dai⁹,Tokka Atsuo¹⁰,Furuyama Hiroaki¹¹,Doi Koji¹²,Hirose Tetsuro¹³,Horimatsu Takahiro¹⁴,Hasegawa Suguru¹,Matsumoto Shigemi¹⁴,Sakai Yoshiharu¹,Uemoto Shinji¹

Affiliation:

1. Department of Surgery, Graduate School of Medicine; Kyoto University; Kyoto Japan

2. Department of Surgery; Shiga Medical Center for Adults; Moriyama Shiga Japan

3. Department of Surgery; Osaka Red Cross Hospital; Osaka Japan

4. Department of Gastroenterological Surgery and Oncology; Kitano Hospital; Osaka Japan

5. Department of Surgery; Kobe City Medical Center General Hospital; Kobe Hyogo Japan

6. Department of Surgery; Saiseikai Noe Hospital; Osaka Japan

7. Department of Surgery; Kansai Electric Power Hospital; Osaka Japan

8. Department of Surgery; Kishiwada City Hospital; Kishiwada Osaka Japan

9. Department of Surgery; Kyoto Katsura Hospital; Kyoto Japan

10. Department of Surgery; Shimane Prefectural Central Hospital; Izumo Shimane Japan

11. Department of Surgery; Tenri Yorozu Hospital; Tenri Nara Japan